Pharmacodynamics, pharmacokinetics and safety of multiple ascending doses of the novel dual glucose‐dependent insulinotropic polypeptide/glucagon‐like peptide‐1 agonist <scp>RG</scp>7697 in people with type 2 diabetes mellitus
Distribution of the number of citations over years.